IE38423L - Neonatal calf diarrhea vaccine. - Google Patents

Neonatal calf diarrhea vaccine.

Info

Publication number
IE38423L
IE38423L IE731925A IE192573A IE38423L IE 38423 L IE38423 L IE 38423L IE 731925 A IE731925 A IE 731925A IE 192573 A IE192573 A IE 192573A IE 38423 L IE38423 L IE 38423L
Authority
IE
Ireland
Prior art keywords
vaccine
calf diarrhea
bovine
virus
coronavirus
Prior art date
Application number
IE731925A
Other versions
IE38423B1 (en
Original Assignee
Univ Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nebraska filed Critical Univ Nebraska
Publication of IE38423L publication Critical patent/IE38423L/en
Publication of IE38423B1 publication Critical patent/IE38423B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

1401565 Calf diarrhea vaccine UNIVERSITY OF NEBRASKA REGENTS OF 23 Oct 1973 [30 Oct 1972] 49253/73 Heading A5B A calf diarrhea vaccine comprises an attenuated or inactivated coronavirus-like calf diarrhea virus. The vaccine may be in the form of a combination vaccine comprising inactivated coronavirus and reovirus, both of which are prepared by inactivating a live virus, either unaaatenuated or attenuated, by chamicals, radiation or heat. Coronavirus can also be combined with bovine adenovirus, bovine virus diarrhea, or other bovine pathogens such as E. Coli or clostridia sp. [GB1401565A]
IE1925/73A 1972-10-30 1973-10-26 Vaccine for nenatal calf diarrhea IE38423B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30217972A 1972-10-30 1972-10-30

Publications (2)

Publication Number Publication Date
IE38423L true IE38423L (en) 1974-04-30
IE38423B1 IE38423B1 (en) 1978-03-15

Family

ID=23166611

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1925/73A IE38423B1 (en) 1972-10-30 1973-10-26 Vaccine for nenatal calf diarrhea

Country Status (17)

Country Link
JP (3) JPS5817169B2 (en)
AR (1) AR200155A1 (en)
AU (1) AU476160B2 (en)
BE (1) BE806568A (en)
CA (1) CA1019675A (en)
CH (1) CH596315A5 (en)
DD (1) DD110517A5 (en)
DE (1) DE2354324C2 (en)
ES (1) ES419996A1 (en)
FI (1) FI52740C (en)
FR (1) FR2204405B1 (en)
GB (1) GB1401565A (en)
HU (1) HU168486B (en)
IE (1) IE38423B1 (en)
NL (1) NL7314293A (en)
SE (1) SE419500B (en)
ZA (1) ZA738329B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027007U (en) * 1983-07-30 1985-02-23 株式会社 協立双葉自動機 Labeling machine with container rotation speed adjustment device
JPH0518338Y2 (en) * 1985-12-27 1993-05-17
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine
GB8818415D0 (en) * 1988-08-03 1988-09-07 Animal Health Inst Vaccine
JPH08786B2 (en) * 1993-02-25 1996-01-10 株式会社微生物化学研究所 Bovine coronavirus infectious disease vaccine
RU2701948C1 (en) 2015-11-06 2019-10-02 Асахи Касеи Медикал Ко., Лтд. Method for producing parvovirus characterized by high infectivity titre and high purity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759425A (en) * 1969-11-28 1971-05-25 Mebus Charles A CALVES DIARRHEA VACCINES, THEIR PREPARATION AND USE
US3629413A (en) * 1970-02-04 1971-12-21 Univ Southern Illinois Polyvalent bovine vaccines and methods of making and using same

Also Published As

Publication number Publication date
CH596315A5 (en) 1978-03-15
AU476160B2 (en) 1976-09-16
SE419500B (en) 1981-08-10
AU6177473A (en) 1975-04-24
JPS5531058A (en) 1980-03-05
JPS6124370B2 (en) 1986-06-10
JPS57131726A (en) 1982-08-14
DE2354324C2 (en) 1982-06-03
DE2354324A1 (en) 1974-05-09
JPS4980230A (en) 1974-08-02
FR2204405B1 (en) 1977-01-28
JPS5817169B2 (en) 1983-04-05
FI52740B (en) 1977-08-01
GB1401565A (en) 1975-07-16
BE806568A (en) 1974-04-26
FI52740C (en) 1977-11-10
AR200155A1 (en) 1974-10-24
JPS5757449B2 (en) 1982-12-04
ES419996A1 (en) 1976-08-01
FR2204405A1 (en) 1974-05-24
CA1019675A (en) 1977-10-25
ZA738329B (en) 1974-09-25
HU168486B (en) 1976-05-28
DD110517A5 (en) 1974-12-20
IE38423B1 (en) 1978-03-15
NL7314293A (en) 1974-05-02

Similar Documents

Publication Publication Date Title
LV10203A (en) A test-kit of a protein composition for the detection of infections with AIDS
IT1190792B (en) PROCEDURE FOR PREPARING BLOOD COAGULANT ENZYME COMPOSITIONS
DE3072205D1 (en) DNS TRANSFER VECTOR, TRANSFORMED HOST, VACCINE AND THEIR PRODUCTION.
ATE410183T1 (en) IMPROVED SAPONIN-BASED ADJUVANT COMPOSITIONS AND RELATED METHODS
CA2022420A1 (en) Escherichia coli vaccine
ES254659U (en) Deformable light-weight housing structure
NO904538L (en) CHEMICAL GYCLOPROTEINS CONTAINING IMMUNOGENIC SEGMENTS OF HUMANT PARAINFLUENNAVIRUS TYPE 3.
IE38423B1 (en) Vaccine for nenatal calf diarrhea
IT1044555B (en) Benzodipyrones - used for treatment of allergic asthma
SE7512828L (en) CALICIVIRUSVACCIN
TW340873B (en) Chicken anaemia agent vaccine
ATE43500T1 (en) PRODUCTION OF ANTIBODIES.
CA961410A (en) Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
IT8024746A0 (en) PROCEDURE AND DEVICE FOR KEEPING FRESH AND PRESERVING PERISHABLE PRODUCTS, PARTICULARLY FOOD PRODUCTS.
CA983851A (en) Killed vaccine for infectious porcine atrophic rhinitis and process for preparing the same
NL300073I1 (en) Vaccine.
DE3361138D1 (en) Ozone inactivated organisms as vaccines
SU565653A1 (en) Method of preservation of bone tissue
GB1036621A (en) Improvements in or relating to bacterial vaccines
GB949400A (en) Poliomyelitis vaccines
before Parliament et al. The Industrial Relations (Code of Practice) Order 1972
AU486934B2 (en) Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
Nicolas et al. Attempt of Vaccination Program Against Sheep Salmonellosis due to Salmonella abortus ovis.
GB1065899A (en) Improvements in or relating to martensitic,age hardening stainless steel
JPS5359023A (en) Inactivation of toxins produced by microbials and attenuation of vaccines